| Grant number: | 09/14884-2 |
| Support Opportunities: | Regular Research Grants |
| Start date: | February 01, 2010 |
| End date: | July 31, 2012 |
| Field of knowledge: | Health Sciences - Medicine - Maternal and Child Health |
| Principal Investigator: | Eliana Aguiar Petri Nahás |
| Grantee: | Eliana Aguiar Petri Nahás |
| Host Institution: | Faculdade de Medicina (FMB). Universidade Estadual Paulista (UNESP). Campus de Botucatu. Botucatu , SP, Brazil |
| City of the host institution: | Botucatu |
Abstract
Cardiovascular disease (CVD), especially coronary artery disease (CAD), comprises the main cause of mortality in postmenopausal women. CHD is caused by the atherosclerotic process of progressive evolution, which involves a number of risk factors such as hypercholesterolemia, smoking, hypertension, diabetes, stress, inactivity and obesity, which cannot be ignored in the approach to climacteric women. Through the estimation of risk, we can suggest the establishment of priority measures for primary and secondary prevention, in an attempt to reduce the occurrence of CAD. However, the detection of early markers would allow the recognition of subclinical atherosclerotic disease with early intervention on modifiable risk factors, important in management of post-menopausal women. Atherosclerosis is a disease of the arterial wall, characterized by inflammation and remodeling that can manifest as acute vascular event, becoming clinically apparent. In CAD, conventional risk factors remain important, but individual differences in immune profile may modulate the severity of the atherosclerotic process. The significance of bio-inflammatory markers in women after menopause and the risk of atherosclerosis is an important area of study. Our hypothesis is that the concentration ratio of heat shock protein (hsp) with cytokines and the expression of Toll-like receptors, correlating with the genetic polymorphism of mannose-binding lecitin (MBL) prognosis is the occurrence of CHD sub-clinical ultrasound in postmenopausal menopause. It is expected that the evaluation of early biomarkers - clinical, immuno-inflammatory and ultrasound - of atherosclerotic disease in women after menopause may be to identify patients at cardiovascular risk or with subclinical disease thus proposing preventive measures effective in reducing the occurrence of manifest disease leading cause of mortality in this population, affecting considerably the quality of life in menopause. (AU)
| Articles published in Agência FAPESP Newsletter about the research grant: |
| More itemsLess items |
| TITULO |
| Articles published in other media outlets ( ): |
| More itemsLess items |
| VEICULO: TITULO (DATA) |
| VEICULO: TITULO (DATA) |